AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EDLAND, R. W.
Right arrow Articles by ANSFIELD, F. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by EDLAND, R. W.
Right arrow Articles by ANSFIELD, F. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

GLIOBLASTOMA MULTIFORME

AN ANALYSIS OF THE RESULTS OF POSTOPERATIVE RADIOTHERAPY ALONE VERSUS RADIOTHERAPY AND CONCOMITANT 5-FLUOROURACIL (A Prospective Randomized Study of 32 Cases)

ROBERT W. EDLAND M.D., MANUCHER JAVID M.D., and FRED J. ANSFIELD M.D.

Between January 1962 and December 1966, 32 patients with a histologically confirmed diagnosis of astrocytoma Grade 3 or 4 (glioblastoma multiforme) were entered into a cooperative, prospectively randomized study to compare the effects of postoperative, high dose, supervoltage radiotherapy alone (17 cases) versus a similar course of postoperative radiotherapy and concomitant systemic 5-fluorouracil chemotherapy (15 cases).

The average survival from diagnosis (incomplete removal) was 11.7 months in the radiotherapy only group and 11.5 months in the combined therapy group.

Two patients are still alive, 1 at 37 months treated by irradiation alone and 1 at 26 months who received combined therapy.

We conclude that combined therapy with 5-fluorouracil offers no advantage, from the standpoint of duration or caliber of survival, over high dose postoperative radiotherapy alone in the management of patients with glioblastoma multiforme.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by the American Roentgen Ray Society.